The domino effect triggered by the tethered ligand of the protease activated receptors
- 4 August 2020
- journal article
- review article
- Published by Elsevier BV in Thrombosis Research
- Vol. 196, 87-98
- https://doi.org/10.1016/j.thromres.2020.08.004
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL098217)
- American Heart Association (18PRE33960396)
- Schwab Charitable Fund
This publication has 149 references indexed in Scilit:
- Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigenProceedings of the National Academy of Sciences of the United States of America, 2013
- High-resolution crystal structure of human protease-activated receptor 1Nature, 2012
- ALIX binds a YPX3L motif of the GPCR PAR1 and mediates ubiquitin-independent ESCRT-III/MVB sortingThe Journal of cell biology, 2012
- Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonistBritish Journal of Pharmacology, 2011
- Identification of an antithrombotic allosteric modulator that acts through helix 8 of PAR1Proceedings of the National Academy of Sciences of the United States of America, 2011
- Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseasesBritish Journal of Pharmacology, 2010
- Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand SiteCell, 2009
- Caveolae are required for protease-selective signaling by protease-activated receptor–1Proceedings of the National Academy of Sciences of the United States of America, 2009
- Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4Proceedings of the National Academy of Sciences of the United States of America, 2007
- Interaction of Thrombin with PAR1 and PAR4 at the Thrombin Cleavage SiteBiochemistry, 2007